Health
FDA Proposes New Ultra-Rare Disease Pathway
FDA proposes a new ultra-rare disease pathway for treatment approval on May 4, 2026, aiming to streamline access for pat…
Sarah Chen·
2 articles
FDA proposes a new ultra-rare disease pathway for treatment approval on May 4, 2026, aiming to streamline access for pat…
A landmark FDA drug approval for a rare disease offers hope to an Overland Park family, highlighting a growing trend in…